메뉴 건너뛰기




Volumn 67, Issue 5, 2010, Pages 371-374

Weight-based heparin protocol using antifactor Xa monitoring

Author keywords

Anticoagulants; Dosage; Heparin; Methodology; Nomograms; Obesity; Protocols; Weight

Indexed keywords

HEPARIN;

EID: 77949612404     PISSN: 10792082     EISSN: None     Source Type: Journal    
DOI: 10.2146/ajhp090123     Document Type: Article
Times cited : (34)

References (18)
  • 1
    • 0021815367 scopus 로고
    • Pharmacist-directed heparin therapy using a standard dosing and monitoring protocol
    • Saya FG, Coleman LT, Martinoff JT. Pharmacist-directed heparin therapy using a standard dosing and monitoring protocol. Am J Hosp Pharm. 1985; 42:1965-9.
    • (1985) Am J Hosp Pharm , vol.42 , pp. 1965-1969
    • Saya, F.G.1    Coleman, L.T.2    Martinoff, J.T.3
  • 2
    • 0027517894 scopus 로고
    • The weight-based heparin dosing nomogram compared with a "standard care" nomogram. A randomized controlled trial
    • Raschke RA, Reilly BM, Guidry JR et al. The weight-based heparin dosing nomogram compared with a "standard care" nomogram. A randomized controlled trial. Ann Intern Med. 1993; 119:874-81.
    • (1993) Ann Intern Med , vol.119 , pp. 874-881
    • Raschke, R.A.1    Reilly, B.M.2    Guidry, J.R.3
  • 3
    • 0029825408 scopus 로고    scopus 로고
    • Comparison of a weight-based heparin nomogram with traditional heparin dosing to achieve therapeutic anticoagulation
    • Shalansky KF, FitzGerald JM, Sunderji R et al. Comparison of a weight-based heparin nomogram with traditional heparin dosing to achieve therapeutic anticoagulation. Pharmacotherapy. 1996; 16:1076-84.
    • (1996) Pharmacotherapy , vol.16 , pp. 1076-1084
    • Shalansky, K.F.1    FitzGerald, J.M.2    Sunderji, R.3
  • 4
    • 0031469010 scopus 로고    scopus 로고
    • Reevaluation of a weight-based heparin dosing nomogram: Is institution-specific modification necessary?
    • Schlicht JR, Sunyecz L, Weber RJ et al. Reevaluation of a weight-based heparin dosing nomogram: is institution-specific modification necessary? Ann Pharmacother. 1997; 31:1454-9.
    • (1997) Ann Pharmacother , vol.31 , pp. 1454-1459
    • Schlicht, J.R.1    Sunyecz, L.2    Weber, R.J.3
  • 5
    • 0031690335 scopus 로고    scopus 로고
    • Weight-based heparin dosing: Clinical response and resource utilization
    • Lackie CL, Luzier AB, Donovan JA et al. Weight-based heparin dosing: clinical response and resource utilization. Clin Ther. 1998; 20:699-710.
    • (1998) Clin Ther , vol.20 , pp. 699-710
    • Lackie, C.L.1    Luzier, A.B.2    Donovan, J.A.3
  • 6
    • 0034650447 scopus 로고    scopus 로고
    • Partnering with nurses to manage heparin therapy with a weight-based protocol
    • Price CK, Colodny L. Partnering with nurses to manage heparin therapy with a weight-based protocol. Am J Health-Syst Pharm. 2000; 57:110-2,115-6.
    • (2000) Am J Health-Syst Pharm , vol.57 , Issue.110-112 , pp. 115-116
    • Price, C.K.1    Colodny, L.2
  • 7
    • 0034796449 scopus 로고    scopus 로고
    • An institution-specific heparin titration nomogram: Development, validation, and assessment of compliance
    • Sherman DS, Clarke SH, Lefkowitz JB et al. An institution-specific heparin titration nomogram: development, validation, and assessment of compliance. Pharmacotherapy. 2001; 21:1167-74.
    • (2001) Pharmacotherapy , vol.21 , pp. 1167-1174
    • Sherman, D.S.1    Clarke, S.H.2    Lefkowitz, J.B.3
  • 8
    • 0032948223 scopus 로고    scopus 로고
    • Problems with monitoring heparin anticoagulation
    • Bussey HI. Problems with monitoring heparin anticoagulation. Pharmacotherapy. 1999; 19:2-5.
    • (1999) Pharmacotherapy , vol.19 , pp. 2-5
    • Bussey, H.I.1
  • 9
    • 0032812237 scopus 로고    scopus 로고
    • Correlation of activated clotting time and activated partial thromboplastin time to plasma heparin concentration
    • Koerber JM, Smythe MA, Begle RL et al. Correlation of activated clotting time and activated partial thromboplastin time to plasma heparin concentration. Pharmacotherapy. 1999; 19:922-31.
    • (1999) Pharmacotherapy , vol.19 , pp. 922-931
    • Koerber, J.M.1    Smythe, M.A.2    Begle, R.L.3
  • 10
    • 0032744959 scopus 로고    scopus 로고
    • Heparin monitoring: The confusion continues
    • Smythe MA, Koerber JM. Heparin monitoring: the confusion continues. Pharmacotherapy. 1999; 19:1240-2.
    • (1999) Pharmacotherapy , vol.19 , pp. 1240-1242
    • Smythe, M.A.1    Koerber, J.M.2
  • 11
    • 33751252564 scopus 로고    scopus 로고
    • Monitoring unfractionated heparin with the aPTT: Time for a fresh look
    • Eikelboom JW, Hirsh J. Monitoring unfractionated heparin with the aPTT: time for a fresh look. Thromb Haemost. 2006; 96:547-52.
    • (2006) Thromb Haemost , vol.96 , pp. 547-552
    • Eikelboom, J.W.1    Hirsh, J.2
  • 12
    • 0033059794 scopus 로고    scopus 로고
    • Monitoring unfractionated heparin therapy with antifactor Xa activity results in fewer monitoring tests and dosage changes than monitoring with the activated partial thromboplastin time
    • Rosborough TK. Monitoring unfractionated heparin therapy with antifactor Xa activity results in fewer monitoring tests and dosage changes than monitoring with the activated partial thromboplastin time. Pharmacotherapy. 1999; 19:760-6.
    • (1999) Pharmacotherapy , vol.19 , pp. 760-766
    • Rosborough, T.K.1
  • 14
    • 3543066284 scopus 로고    scopus 로고
    • I; for the Heparin Consensus Group. Challenges in variation and responsiveness of unfractionated heparin
    • Francis FL, Groce JB III; for the Heparin Consensus Group. Challenges in variation and responsiveness of unfractionated heparin. Pharmacotherapy. 2004; 24(8, pt 2):108S-119S.
    • (2004) Pharmacotherapy , vol.24 , Issue.8 PART 2
    • Francis, F.L.1    Groce II, J.B.2
  • 15
    • 2942614745 scopus 로고    scopus 로고
    • Achieving target antifactor Xa activity with a heparin protocol based on sex, age, height, and weight
    • Rosborough TK, Shepherd MF. Achieving target antifactor Xa activity with a heparin protocol based on sex, age, height, and weight. Pharmacotherapy. 2004; 24:713-9.
    • (2004) Pharmacotherapy , vol.24 , pp. 713-719
    • Rosborough, T.K.1    Shepherd, M.F.2
  • 16
    • 0031784749 scopus 로고    scopus 로고
    • In unfractionated heparin dosing, the combination of patient age and estimated plasma volume predicts initial antifactor Xa activity better than patient weight alone
    • Rosborough TK. In unfractionated heparin dosing, the combination of patient age and estimated plasma volume predicts initial antifactor Xa activity better than patient weight alone. Pharmacotherapy. 1998; 18:1217-23.
    • (1998) Pharmacotherapy , vol.18 , pp. 1217-1223
    • Rosborough, T.K.1
  • 17
    • 0031937523 scopus 로고    scopus 로고
    • Optimal weight base for a weight-based heparin dosing protocol
    • Yee WP, Norton LL. Optimal weight base for a weight-based heparin dosing protocol. Am J Health-Syst Pharm. 1998; 55:159-62.
    • (1998) Am J Health-Syst Pharm , vol.55 , pp. 159-162
    • Yee, W.P.1    Norton, L.L.2
  • 18
    • 0035890018 scopus 로고    scopus 로고
    • Achievement of anticoagulation by using a weight-based heparin dosing protocol for obese and nonobese patients
    • Spruill WJ, Wade WE, Huckaby WG et al. Achievement of anticoagulation by using a weight-based heparin dosing protocol for obese and nonobese patients. Am J Health-Syst Pharm. 2001; 58:2143-6.
    • (2001) Am J Health-Syst Pharm , vol.58 , pp. 2143-2146
    • Spruill, W.J.1    Wade, W.E.2    Huckaby, W.G.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.